Cooper University Health Care First in the Region to Implant the World’s First Neuromodulation Device to Treat Symptoms of Heart Failure
Cooper University Health Care recently performed the region’s first successful implant of Barostim™ Baroreflex Activation Therapy, the world’s first FDA-approved heart failure device to use neuromodulation—the power of the brain and nervous system—to improve the symptoms of patients with systolic heart failure. This therapy was designed to treat heart failure patients who may not be receiving adequate symptom relief from medications alone. Read more.